New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2013
10:25 EDTRPTP, RPTPLazard's healthcare analyst research team holds analyst/industry conference call
Healthcare Analyst Research Team, along with a physician expert, discusses Raptor Pharmaceuticals' Procysbi, the next big thing in Heophropathic Cystinosis on an Analyst/Industry conference call to be held on February 28 at 11 am.
News For RPTP From The Last 14 Days
Check below for free stories on RPTP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
08:58 EDTRPTPRaptor Pharma should be owned ahead of potential catalysts, says JMP Securities
JMP Securities believes that Raptor has a number of potentially transformative upcoming catalysts. The firm thinks that adoption of the company's Proscybi drug could be a number of times higher than current levels, and it thinks that data due to be released over the next several months could be transformative for the company. The firm reiterates a $33 price target and Outperform rating.
September 11, 2014
09:38 EDTRPTPRaptor Pharmaceuticals management to meet with JMP Securities
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use